Cincinnati, OHNCT07497607Now EnrollingIRB Ready

Oropharyngeal Squamous Cell Carcinoma Clinical Trial in Cincinnati, OH

Access cutting-edge oropharyngeal squamous cell carcinoma treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.

Sponsored by Sara Medek

Quick Self-Assessment

See if you qualify for this Cincinnati location

Preparing your pre-screening questions…

Expert Care in Cincinnati

Access oropharyngeal squamous cell carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related oropharyngeal squamous cell carcinoma treatment provided free

Apply for This Cincinnati Location

Check if you qualify for this oropharyngeal squamous cell carcinoma clinical trial in Cincinnati, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cincinnati

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cincinnati site if eligible
  4. 4Begin participation

About This Oropharyngeal Squamous Cell Carcinoma Study in Cincinnati

This is a single-arm, phase II study that is designed to investigate nodal and primary tumor CTV dose de-escalation (30 Gy) in HPV positive oropharyngeal cancer.

Sponsor: Sara Medek

Who Can Participate

Inclusion Criteria

Patients must have histologically or cytologically confirmed history of squamous cell carcinoma of the oropharynx (OPSCC) planned for definitive chemoradiation.
Squamous cell carcinoma of the oropharynx (OPSCC) must be confirmed to be p16 positive based on immunohistochemical staining.
OPSCC must be clinical stage T1-4N1-3M0 or T3-T4N0M0 as per AJCC volume 8.
Patients must have measurable disease based on PET/CT imaging completed within 45 days +/- 1 week from date of eligibility confirmation.
Age ≥18 years.
ECOG performance status ≤2.
Patients must be deemed eligible for planned SOC cisplatin per treating investigators and/or treating medical oncologist.
Women of child-bearing potential and men must agree to use adequate contraception (e.g., hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation.
Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria

1\. Patients with metastatic or recurrent disease. 2\. Carcinoma of the neck of unknown primary site origin (T0 is ineligible even if p16 is positive). 3\. Prior radiotherapy resulting in overlap of radiation therapy fields. 4\. Patients who are pregnant, nursing or intended to conceive or father children during the course of the study. 5\. Patients with active autoimmune or connective tissue disease that require systemic treatment in the opinion of the Investigator. 6\. Patients who are receiving any other investigational agents. Patients who have received other investigational agents previously who are no longer receiving these investigational agents may be eligible at the discretion of the Investigator. 7\. Patients with uncontrolled intercurrent illness or any other significant condition(s) that would make participation in this protocol unreasonably hazardous or not preferable, in the opinion of the Investigator.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT07497607) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Oropharyngeal Squamous Cell Carcinoma Treatment Options in Cincinnati, OH

If you're searching for oropharyngeal squamous cell carcinoma treatment options in Cincinnati, OH, this clinical trial (NCT07497607) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced oropharyngeal squamous cell carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all oropharyngeal squamous cell carcinoma clinical trials near you to find additional studies recruiting in your area.

More Head and Neck Cancer Trials in Cincinnati, OH

See all head and neck cancer clinical trials recruiting in Cincinnati — not just this study.

Browse Head and Neck Cancer Trials in Cincinnati →

Browse More Trials by Condition

Head and Neck Cancer TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Cincinnati?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cincinnati, OH